IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
IPSEN

PRESS RELEASE

published on 10/23/2024 at 07:00, 1 month 29 days ago

Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2024 et revoit à la hausse ses prévisions pour l'exercice en cours
BRIEF

published on 09/23/2024 at 11:01, 2 months 28 days ago

Parvus Asset Management crosses threshold in IPSEN SA

Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
BRIEF

published on 09/23/2024 at 11:01, 2 months 28 days ago

Franchissement de seuil par Parvus Asset Management dans IPSEN SA

Euronext Paris Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management
PRESS RELEASE

published on 09/23/2024 at 10:56, 2 months 28 days ago

Franchissement de seuil
Déclaration de franchissement de seuil par Parvus Asset Management Europe Limited pour le compte de clients et fonds détenant 7,80% du capital d'IPSEN SA

Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management Cession Actions
BRIEF

published on 09/16/2024 at 14:50, 3 months 5 days ago

Promising results for Cabometyx in advanced neuroendocrine tumors

Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
BRIEF

published on 09/16/2024 at 14:50, 3 months 5 days ago

Des résultats prometteurs pour Cabometyx dans les tumeurs neuroendocrines avancées

Phase III Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
PRESS RELEASE

published on 09/16/2024 at 14:45, 3 months 5 days ago

Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM

Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
PRESS RELEASE

published on 09/16/2024 at 14:45, 3 months 5 days ago

Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées
Les résultats finaux de l’essai de Phase III CABINET confirment l’efficacité de Cabometyx dans les tumeurs neuroendocrines avancées. Ipsen publie les données au congrès ESMO 2024

Essai Clinique Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
BRIEF

published on 09/15/2024 at 14:50, 3 months 6 days ago

New analysis of the CONTACT-02 trial by Ipsen

Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx
BRIEF

published on 09/15/2024 at 14:50, 3 months 6 days ago

Nouvelle analyse de l'essai CONTACT-02 par Ipsen

Essai Clinique Ipsen Cancer De La Prostate CONTACT-02 Cabometyx

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 46 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 46 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 11 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 16 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 46 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 24 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 30 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 6 hours 58 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 58 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE